Skip to main content
OpenTrials
Completed

NCT Number: NCT01824797

Bone Metabolism After Bariatric Surgery

The purpose and objective of this study is to determine the changes in bone metabolism after bariatric surgery in postmenopausal women.

This is a prospective cohort study that will enroll up to 40 postmenopausal female subjects with class II and III obesity from the Duke Center for Metabolic and Weight Loss Surgery. The study team will enroll subjects that are already being scheduled for either sleeve gastrectomy or Roux-en-Y gastric bypass. The osteoclast activity, the osteoblast activity, and the bone mineral density will be measured in all subjects preoperatively and 12 months postoperatively through research specific blood tests and Dual energy x-ray Absorptiometry (DEXA) scans.

The primary endpoints are change in osteoclast activity as measured by C-terminal telopeptide of type I collagen and change in bone density as measured by DEXA scan. These are continuous variable and given the small sample size the investigators will use a nonparametric Wilcoxon rank-sum test to compare the difference in one year change in these variables. There is a slight risk of loss of confidentiality. Every effort will be made to protect all PHI. There is also the risk of increased exposure to radiation from the DEXA scans performed twice with each subjects participating in the study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Duke Center for Metabolic and Weight Loss Surgery

Durham, North Carolina, 27704, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Postmenopausal women as determined by having a history of no menstrual bleed for greater than one year.
  • Body Mass Index ≥35 kg/m² and stable weight for the previous 3 months.
  • Able to speak and read English.
  • Being scheduled for either Roux-en-Y gastric bypass or sleeve gastrectomy.

Exclusion criteria

  • A documented history of osteoporosis or currently receiving medical treatment for osteoporosis with bisphosphonates, teriparatide, raloxifene, or denosumab.
  • Weight greater than 295 pounds as this is the weight limit for our Dual-energy X-ray absorptiometry machine.
  • Current or past (less than 1 year from enrollment) usage of estrogen hormone replacement therapy.
  • Current smoker
  • Any history of glucocorticoid use greater than one year in duration or current use of glucocorticoids.

Treatment and study plan

Primary outcomes

  1. Changes in Bone Mineral Density

    Time frame: Baseline to one year postoperative

    Changes in bone mineral density will be determined by comparing a peroperative DEXA scan with a one year postoperative DEXA scan on postmenopausal subjects who have already planned to undergo Roux-en-Y gastric bypass or sleeve gastrectomy.

Secondary outcomes

  1. Biochemical Changes in Bone Metabolism

    Time frame: Baseline to one year postoperative

    Serum will be collected from the subjects preoperatively and 12 months postoperatively. The serum will be used at the completion of the study to run enzyme-linked immunosorbent assay (ELISA) to determine biochemical changes in their bone metabolism.

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Society of American Gastrointestinal and Endoscopic Surgeons

Registry information

Official study title

Determining Changes in Bone Metabolism After Bariatric Surgery in Postmenopausal Women

Important dates

Study start
2013
Primary completion
2018
Study completion
2018
First posted
Apr 5, 2013
Registry last updated
Aug 16, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.